EQWL Fact Sheet: Invesco S&P 100 Equal Weight ETF
Share
$128.62
close, Nov 18, 2026
Over the year to Nov 18, 2026, EQWL returned +14.3% in total and charged 0.25% a year.
- 1-year total return
- +14.3%
- to Nov 18, 2026
- Expense ratio
- 0.25%
- a year
- Net assets
- $2.7bn
- on Nov 17, 2026
- Net flow, last 5 trading days
- +$15.9m
- daily basis to Nov 17, 2026
Growth of $10,000, 1 year
EQWL $11,427 +14.3% · Total return, distributions reinvested, Nov 18, 2025 to Nov 18, 2026.
Returns
WindowTotal return
1 month−1.8%
3 months−4.6%
Year to date+10.2%
1 year+14.3%
3 years+66.0%
5 years+67.1%
Total return, distributions reinvested, each window to Nov 18, 2026.
Ten largest positions
HoldingWeight
Accenture PLC1.38%
Eli Lilly & Co1.28%
Costco Wholesale Corp1.25%
Intuitive Surgical Inc1.24%
Walmart Inc1.23%
Procter & Gamble Co1.22%
Amgen Inc1.19%
Gilead Sciences Inc1.19%
AbbVie Inc1.19%
Berkshire Hathaway Inc1.18%
EQWL top ten by weight, 12.3% of the fund, of its 103 equity positions, from the holdings published by its issuer for Nov 17, 2026.
Facts
Equity fund · Tracks the S&P 100 Equal Weight Index · First traded Dec 1, 2006 · Benchmark Its own holdings, as of Nov 17, 2026